Orlando M Gutiérrez1, Suzanne E Judd2, Marguerite R Irvin3, Degui Zhi2, Nita Limdi4, Nicholette D Palmer5, Stephen S Rich6, Michèle M Sale6, Barry I Freedman7. 1. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. 2. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA. 3. Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. 4. Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA. 5. Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA. 6. Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA. 7. Department of Internal Medicine-Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Abstract
BACKGROUND: Two independent coding variants in the apolipoprotein L1 gene (APOL1), G1 and G2, strongly associate with nephropathy in African Americans; associations with cardiovascular disease are more controversial. Although APOL1 binds plasma high-density lipoproteins (HDLs), data on APOL1 risk variant associations with HDL subfractions are sparse. METHODS: Two APOL1 G1 single nucleotide polymorphisms and the G2 insertion/deletion polymorphism were genotyped in 2010 Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study participants with nuclear magnetic resonance spectroscopy-based lipoprotein subfraction measurements. Linear regression was used to model associations between numbers of APOL1 G1/G2 risk variants and HDL subfractions, adjusting for demographic, clinical and ancestral covariates. RESULTS: Female sex and higher percentage of African ancestry were positively associated with the number of APOL1 G1/G2 risk alleles. In the unadjusted analysis, mean (standard error) small HDL concentrations (μmol/L) for participants with zero, one and two G1/G2 risk alleles were 19.0 (0.2), 19.7 (0.2) and 19.9 (0.4), respectively (P = 0.02). Adjustment for age, sex, diabetes and African ancestry did not change the results but strengthened the statistical significance (P = 0.004). No significant differences in large or medium HDL, very low-density lipoprotein or low-density lipoprotein particle concentrations were observed by APOL1 genotype. CONCLUSIONS: Greater numbers of APOL1 G1/G2 risk alleles were associated with higher small HDL particle concentrations in African Americans. These results may suggest novel areas of investigation to uncover reasons for the association between APOL1 risk variants with adverse outcomes in African Americans.
BACKGROUND: Two independent coding variants in the apolipoprotein L1 gene (APOL1), G1 and G2, strongly associate with nephropathy in African Americans; associations with cardiovascular disease are more controversial. Although APOL1 binds plasma high-density lipoproteins (HDLs), data on APOL1 risk variant associations with HDL subfractions are sparse. METHODS: Two APOL1 G1 single nucleotide polymorphisms and the G2 insertion/deletion polymorphism were genotyped in 2010 Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study participants with nuclear magnetic resonance spectroscopy-based lipoprotein subfraction measurements. Linear regression was used to model associations between numbers of APOL1 G1/G2 risk variants and HDL subfractions, adjusting for demographic, clinical and ancestral covariates. RESULTS: Female sex and higher percentage of African ancestry were positively associated with the number of APOL1 G1/G2 risk alleles. In the unadjusted analysis, mean (standard error) small HDL concentrations (μmol/L) for participants with zero, one and two G1/G2 risk alleles were 19.0 (0.2), 19.7 (0.2) and 19.9 (0.4), respectively (P = 0.02). Adjustment for age, sex, diabetes and African ancestry did not change the results but strengthened the statistical significance (P = 0.004). No significant differences in large or medium HDL, very low-density lipoprotein or low-density lipoprotein particle concentrations were observed by APOL1 genotype. CONCLUSIONS: Greater numbers of APOL1 G1/G2 risk alleles were associated with higher small HDL particle concentrations in African Americans. These results may suggest novel areas of investigation to uncover reasons for the association between APOL1 risk variants with adverse outcomes in African Americans.
Authors: P N Duchateau; C R Pullinger; R E Orellana; S T Kunitake; J Naya-Vigne; P M O'Connor; M J Malloy; J P Kane Journal: J Biol Chem Date: 1997-10-10 Impact factor: 5.157
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Andreas Festa; Ken Williams; Anthony J G Hanley; James D Otvos; David C Goff; Lynne E Wagenknecht; Steven M Haffner Journal: Circulation Date: 2005-06-28 Impact factor: 29.690
Authors: Alicia J Jenkins; Timothy J Lyons; Deyi Zheng; James D Otvos; Daniel T Lackland; Daniel McGee; W Timothy Garvey; Richard L Klein Journal: Kidney Int Date: 2003-09 Impact factor: 10.612
Authors: D S Freedman; J D Otvos; E J Jeyarajah; J J Barboriak; A J Anderson; J A Walker Journal: Arterioscler Thromb Vasc Biol Date: 1998-07 Impact factor: 8.311
Authors: Kaoru Ito; Alexander G Bick; Jason Flannick; David J Friedman; Giulio Genovese; Michael G Parfenov; Steven R Depalma; Namrata Gupta; Stacey B Gabriel; Herman A Taylor; Ervin R Fox; Christopher Newton-Cheh; Sekar Kathiresan; Joel N Hirschhorn; David M Altshuler; Martin R Pollak; James G Wilson; J G Seidman; Christine Seidman Journal: Circ Res Date: 2013-12-30 Impact factor: 17.367
Authors: Katya B Rubinow; Clark M Henderson; Cassianne Robinson-Cohen; Jonathan Himmelfarb; Ian H de Boer; Tomas Vaisar; Bryan Kestenbaum; Andrew N Hoofnagle Journal: Kidney Int Date: 2017-07-26 Impact factor: 10.612
Authors: Alexander G Bick; Elvis Akwo; Cassianne Robinson-Cohen; Kyung Lee; Julie Lynch; Themistocles L Assimes; Scott DuVall; Todd Edwards; Huaying Fang; S Matthew Freiberg; Ayush Giri; Jennifer E Huffman; Jie Huang; Leland Hull; Rachel L Kember; Derek Klarin; Jennifer S Lee; Michael Levin; Donald R Miller; Pradeep Natarajan; Danish Saleheen; Qing Shao; Yan V Sun; Hua Tang; Otis Wilson; Kyong-Mi Chang; Kelly Cho; John Concato; J Michael Gaziano; Sekar Kathiresan; Christopher J O'Donnell; Daniel J Rader; Philip S Tsao; Peter W Wilson; Adriana M Hung; Scott M Damrauer Journal: Circulation Date: 2019-07-24 Impact factor: 29.690
Authors: Allison Weckerle; James A Snipes; Dongmei Cheng; Abraham K Gebre; Julie A Reisz; Mariana Murea; Gregory S Shelness; Gregory A Hawkins; Cristina M Furdui; Barry I Freedman; John S Parks; Lijun Ma Journal: J Lipid Res Date: 2015-11-18 Impact factor: 5.922
Authors: Orlando M Gutiérrez; Marguerite R Irvin; Neil A Zakai; Rakhi P Naik; Ninad S Chaudhary; Michelle M Estrella; Sophie Limou; Suzanne E Judd; Mary Cushman; Jeffrey B Kopp; Cheryl A Winkler Journal: Am J Kidney Dis Date: 2019-09-26 Impact factor: 8.860
Authors: Orlando M Gutiérrez; Marguerite R Irvin; Ninad S Chaudhary; Mary Cushman; Neil A Zakai; Victor A David; Sophie Limou; Nathalie Pamir; Alex P Reiner; Rakhi P Naik; Michele M Sale; Monika M Safford; Hyacinth I Hyacinth; Suzanne E Judd; Jeffrey B Kopp; Cheryl A Winkler Journal: Circ Genom Precis Med Date: 2018-06
Authors: Teresa K Chen; Josef Coresh; Natalie Daya; Shoshana H Ballew; Adrienne Tin; Deidra C Crews; Morgan E Grams Journal: J Am Geriatr Soc Date: 2020-09-07 Impact factor: 5.562